Cell membrane fluidity and adriamycin retention in a tumor progression movel of AKR lymphoma
- 11 June 1996
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1281 (2) , 182-188
- https://doi.org/10.1016/0005-2736(96)00016-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phosphorylation of the Multidrug Resistance Encoded Protein P190Biochemistry, 1995
- Malignant phenotype correlating with drug resistance in two human neuroblastoma cell linesJournal of Neuro-Oncology, 1994
- Effect of a Membrane-Active Agent on Uptake of Adriamycin in Lewis Lung Carcinoma Cells Derived from ‘Primary’ and ‘Metastatic’ GrowthsChemotherapy, 1992
- HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase IIJNCI Journal of the National Cancer Institute, 1990
- Multidrug ResistancePublished by Elsevier ,1989
- Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment StrategiesPublished by Elsevier ,1985
- Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cellsCancer Letters, 1984
- Cell surface molecules and tumor metastasis: Regulation of metastatic phenotypic diversityExperimental Cell Research, 1984
- Metastatic Potential Is Positively Correlated with Cell Surface Sialylation of Cultured Murine Tumor Cell LinesScience, 1981
- Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cellsJournal of Molecular Biology, 1974